drugset / Trial / NCT00396487

Tailored Treatment in Metastatic Colorectal Cancer

NCT00396487 ↗

Phase 3 Terminated 1 enrolled Vejle Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the response rate of single agent chemotherapy in advanced colorectal cancer given as standard treatment versus tailored treatment in a randomised phase III trial.

Timeline

Start
2006-11
Primary completion
—
Completion
2008-02

Outcome

Outcome not reported

Stopped: “Only one patient included as per Feb. 4, 2008.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule — —
Subject Irinotecan Small molecule — —
Subject fluorouracil Small molecule — —
Background Calciumfolinat Unknown — —

Indications